3 completed, 2 recruiting, 2 unknown. 7 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 7 | Completed 3, Recruiting 2, Unknown 2 |
Follow Immune Checkpoint Inhibitors: new trials by email Literature Review of Immune Checkpoint Inhibitors trials Research Report on Immune Checkpoint Inhibitors
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| DETERMINANTS OF IMMUNOTHERAPY EFFICACY IN ENDOMETRIAL CANCER Prospective exploratory cohort - Endometrial Cancer, Immune Checkpoint Inhibitors | Not applicable | Recruiting | European Institute of Oncology | 510 | 2026-04-14 | 2026-07-08 |
| Fertility and Pregnancy After Avelumab Treatment Telephone interview - Gestational Trophoblastic Tumours, Immune Checkpoint Inhibitors | Not applicable | Unknown | Hospices Civils de Lyon | 50 | 2024-04-01 | 2024-03-15 |
| Fecal Microbiota Transplantation in Patients With Malignancies Not Responding to Cancer Immunotherapy Fecal Microbiota Transplantation (FMT) - Cancer, Fecal Microbiota Transplantation | Not applicable | Completed | Michael Scharl | 18 | 2022-03-14 | 2025-03-28 |
| Identification of Predictive Biomarkers for Immune-Related Adverse Events (irAEs) in Patients Undergoing Immune CheckPoint Inhibitors (ICPI) Treatment blood retriewal - Immunotherapy, Immune Checkpoint Inhibitors | Not applicable | Recruiting | Centre Hospitalier Universitaire, Amiens | 150 | 2021-07-02 | 2025-06-04 |
| Relationship Between Immunity and Metabolism in Patients Receiving Immune Checkpoint Inhibitors for Advanced Cancer. ( RIMEC ) calorimetry, impedance measurement at baseline and after 3 months of treatment - Metabolism Disorder, Cancer | Not applicable | Unknown | Assistance Publique - Hôpitaux de Paris | 48 | 2021-05-10 | 2024-07-11 |
| Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer Educational Video and QPL List, Usual Care - Stage IV Melanoma, Advanced Lung Cancer | Not applicable | Completed | Massachusetts General Hospital | 199 | 2021-01-23 | 2026-08-25 |
| Impact of Therapeutic Patient Education on the Toxicity of Immune Checkpoint Inhibitors in Oncology Therapeutic education program, Usual Information - Therapeutic Patient Education, Immune Checkpoint Inhibitors | Not applicable | Completed | Institut Cancerologie de l'Ouest | 412 | 2019-12-11 | 2026-08-31 |
Carcinoma, Renal Cell (2) · Endometrial Neoplasms (2) · Melanoma (2) · Neoplasms (2) · Breast Neoplasms (1) · Carcinoma, Basal Cell (1) · Carcinoma, Merkel Cell (1) · Carcinoma, Non-Small-Cell Lung (1) · Colorectal Neoplasms (1) · Esophageal Neoplasms (1) · Head and Neck Neoplasms (1) · Liver Neoplasms (1) · Mesothelioma (1) · Metabolic Diseases (1) · Squamous Cell Carcinoma of Head and Neck (1)
Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Neoplasms (3) · Neoplasms by Site (3) · Urogenital Diseases (3) · Urogenital Neoplasms (3) · Adenocarcinoma (2) · Carcinoma (2) · Genital Diseases (2) · Genital Diseases, Female (2) · Genital Neoplasms, Female (2) · Kidney Diseases (2) · Kidney Neoplasms (2) · Male Urogenital Diseases (2) · Neoplasms by Histologic Type (2)
Fecal Microbiota Transplantation (1) · Interviews as Topic (1)
Assistance Publique - Hôpitaux de Paris (1) · Centre Hospitalier Universitaire, Amiens (1) · European Institute of Oncology (1) · Hospices Civils de Lyon (1) · Institut Cancerologie de l'Ouest (1) · Massachusetts General Hospital (1) · Michael Scharl (1)
France (4) · Italy (1) · Switzerland (1) · United States (1)
Charles Vauchier (1) · Ilaria Betella (1) · Laura A Petrillo, MD (1) · Michael Scharl, Prof. Dr. (1) · Nathalie Beaumont (1)